SUI Group Holdings (SUIG) grants director multi-tranche warrants expiring 2031
Rhea-AI Filing Summary
Campbell Kristina Stanier reported disposition transactions in this Form 4 filing.
SUI Group Holdings Ltd. reported that director Kristina Stanier Campbell received a one-time equity grant in the form of warrants for common stock upon her appointment to the board effective July 6, 2026. The grant consists of three warrant tranches for 41,513 underlying shares each with exercise prices of $7.0460, $6.5040 and $5.9620, and one tranche for 83,026 underlying shares at $5.4200, all expiring on July 6, 2031. Each tranche vests in four equal installments: 25% on January 6, 2027, 25% on July 6, 2027, 25% on January 6, 2028 and 25% on July 6, 2028.
Positive
- None.
Negative
- None.
Insider Trade Summary
4 transactions reported
Mixed
4 txns
Insider
Campbell Kristina Stanier
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Warrant for Common Stock F1, F2 | 83,026 | $0.00 | $0.00 |
| Grant/Award | Warrant for Common Stock F1, F2 | 41,513 | $0.00 | $0.00 |
| Grant/Award | Warrant for Common Stock F1, F2 | 41,513 | $0.00 | $0.00 |
| Grant/Award | Warrant for Common Stock F1, F2 | 41,513 | $0.00 | $0.00 |
Holdings After Transaction:
Warrant for Common Stock — 207,565 shares (Direct)
Footnotes (2)
- F1. Represents one-time equity grant as part of the Reporting Person's non-management director compensation upon her appointment to the Issuer's Board of Directors, effective July 6, 2026.
- F2. The warrants vest as follows: 25% of each tranche of the warrants become exercisable on January 6, 2027, 25% of each tranche of the warrants will become exercisable on July 6, 2027, 25% of each tranche of the warrants will become exercisable on January 6, 2028, and 25% of each tranche of the warrants will become exercisable on July 6, 2028.
Key Figures
Warrant tranche shares: 41,513 warrants
Warrant tranche exercise price: $7.0460 per share
Warrant tranche exercise price: $6.5040 per share
+5 more
8 metrics
Warrant tranche shares
41,513 warrants
One of three warrant tranches with 41,513 underlying common shares each
Warrant tranche exercise price
$7.0460 per share
Exercise price for a 41,513-share warrant tranche
Warrant tranche exercise price
$6.5040 per share
Exercise price for a 41,513-share warrant tranche
Warrant tranche exercise price
$5.9620 per share
Exercise price for a 41,513-share warrant tranche
Largest warrant tranche shares
83,026 warrants
Warrant tranche with 83,026 underlying common shares at $5.4200
Warrant exercise price
$5.4200 per share
Exercise price for the 83,026-share warrant tranche
Warrant expiration date
July 6, 2031
Expiration date for all four warrant tranches granted to the director
Initial vesting date
January 6, 2027
First 25% vesting date for each warrant tranche
Key Terms
non-management director compensation, warrants, tranche, vest
4 terms
non-management director compensation financial
"Represents one-time equity grant as part of the Reporting Person's non-management director compensation"
warrants financial
"The warrants vest as follows: 25% of each tranche of the warrants become exercisable"
Warrants are special documents that give you the right to buy a company's stock at a set price before a certain date. They are often used as a way for companies to attract investors or raise money, and their value can increase if the company's stock price goes up.
tranche financial
"25% of each tranche of the warrants become exercisable on January 6, 2027"
A tranche is one slice of a larger financing or investment that is released, sold, or paid out in separate parts rather than all at once. Investors care because each slice can carry different risk, return and timing—like buying pieces of a cake where some slices are richer or come later—so the specific tranche you hold affects when you get paid and how much you might gain or lose.
vest financial
"The warrants vest as follows: 25% of each tranche of the warrants become exercisable"
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transaction did SUI Group Holdings (SUIG) report for Kristina Stanier Campbell?
SUI Group Holdings reported a one-time equity grant to director Kristina Stanier Campbell in the form of warrants for common stock upon her July 6, 2026 appointment to the board, structured in four tranches with different exercise prices and a 2031 expiration.
How many SUI Group (SUIG) warrant tranches were granted to the director and at what exercise prices?
The director received four warrant tranches: three tranches each over 41,513 underlying shares with exercise prices of $7.0460, $6.5040 and $5.9620, and one tranche over 83,026 underlying shares with an exercise price of $5.4200, all for common stock.
What is the vesting schedule for the SUI Group (SUIG) director warrant grant?
Each warrant tranche vests in four equal 25% installments: on January 6, 2027, July 6, 2027, January 6, 2028, and July 6, 2028. After these dates, the respective portions of each tranche become exercisable for common stock.
When do the SUI Group (SUIG) director warrants expire?
All four warrant tranches granted to the director have a common expiration date of July 6, 2031. After that date, any unexercised portion of the warrants will no longer be exercisable for SUI Group Holdings common stock.
Was the SUI Group (SUIG) director warrant grant part of management compensation?
The warrants represent a one-time equity grant as part of the reporting person’s non-management director compensation upon appointment to the board, effective July 6, 2026, rather than a management or executive officer compensation package.
Are the SUI Group (SUIG) director warrant transactions reported under a Rule 10b5-1 trading plan?
The filing indicates the Rule 10b5-1 checkbox is not marked, and there is no footnote stating that the director’s warrant grant was made pursuant to a Rule 10b5-1 or other pre-arranged trading plan.